Cargando…

Anlotinib combined with temozolomide for the treatment of patients with diffuse midline glioma: a case report and literature review

BACKGROUND: Diffuse midline glioma with a histone H3-K27M mutation is a brand-new tumor entity according to the 2016 edition of World Health Organization (WHO) classification. As diffuse midline gliomas are aggressive and incurable brain tumors, characterized by high levels of intrinsic and acquired...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yiping, Xu, Qingsheng, Fang, Minwei, Hu, Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641137/ https://www.ncbi.nlm.nih.gov/pubmed/36388022 http://dx.doi.org/10.21037/tcr-22-1073

Ejemplares similares

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
por: Yang, Qunying, et al.
Publicado: (2021)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
por: ABE, Hideaki, et al.
Publicado: (2018)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
por: Abe, Hideaki, et al.
Publicado: (2020)

Immunotherapy approaches for the treatment of diffuse midline gliomas
por: Bernstock, Joshua D., et al.
Publicado: (2022)

Targeted therapy with anlotinib for a H3K27M mutation diffuse midline glioma patient with PDGFR-α mutation: a case report
por: Wang, Qiang, et al.
Publicado: (2021)

Correction to: Targeted therapy with anlotinib for a H3K27M-mutant diffuse midline glioma patient with PDGFR‑α mutation: a case report
por: Wang, Qiang, et al.
Publicado: (2022)

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
por: Di Ruscio, Valentina, et al.
Publicado: (2022)

Interdisciplinary care of children with diffuse midline glioma
por: Coleman, Christina, et al.
Publicado: (2022)

The promise of metabolic imaging in diffuse midline glioma
por: Lovibond, Samantha, et al.
Publicado: (2023)

NUT midline carcinoma as a primary lung tumor treated with anlotinib combined with palliative radiotherapy: a case report
por: Jiang, Jin, et al.
Publicado: (2022)

Diffuse midline glioma in Ollier disease: A case report and a brief review of the literature
por: Karabulut, Ahmet Kasım, et al.
Publicado: (2021)

CNSC-01. GABAERGIC NEURON-TO-GLIOMA SYNAPSES IN DIFFUSE MIDLINE GLIOMAS
por: Barron, Tara, et al.
Publicado: (2023)

A homogeneous treatment for non-DIPG diffuse midline glioma
por: Schiavello, Elisabetta, et al.
Publicado: (2022)

Spinal cord diffuse midline glioma with postoperative acute swelling: A case report and review of literature
por: Karita, Hiroki, et al.
Publicado: (2023)

Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma
por: Park, Changhee, et al.
Publicado: (2021)

Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
por: Hayden, Elisha, et al.
Publicado: (2021)

DIPG-44. DIFFUSE MIDLINE GLIOMA WITH EXTRACRANIAL METASTASIS
por: Larsen, Alexandra Giantini, et al.
Publicado: (2023)

Bone metastases in an adult patient with diffuse midline glioma: a case report
por: Li, Shaoqun, et al.
Publicado: (2020)

Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma
por: She, Lei, et al.
Publicado: (2021)

DIPG-61. Preclinical efficacy of combined radiotherapy with venetoclax treatment in targeting diffuse midline gliomas
por: Madhavan, Krishna, et al.
Publicado: (2022)

Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway
por: Xu, Peng, et al.
Publicado: (2022)

Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation
por: Hou, Zhiwei, et al.
Publicado: (2023)

Radio-Resistance and DNA Repair in Pediatric Diffuse Midline Gliomas
por: Pedersen, Henriette, et al.
Publicado: (2020)

Diffuse midline glioma in the spinal cord with rapid respiratory deterioration
por: Kamidani, Ryo, et al.
Publicado: (2020)

DIPG-39. New preclinical models for Diffuse Midline Glioma
por: Klenner, Marbod, et al.
Publicado: (2022)

DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)
por: Holliday, Holly, et al.
Publicado: (2022)

Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma
por: Miguel Llordes, Gloria, et al.
Publicado: (2023)

Diffuse midline glioma treated with epigenetic agent-based immunotherapy
por: Jing, Linkai, et al.
Publicado: (2023)

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
por: Jackson, Evangeline R., et al.
Publicado: (2023)

DIPG-28. IDENTIFICATION AND TARGETING OF METABOLIC VULNERABILITIES IN COMBINATION WITH PDGFRA-INHIBITION IN DIFFUSE MIDLINE GLIOMA
por: Neyazi, Sina, et al.
Publicado: (2023)

A Protocol for the Generation of Treatment-naïve Biopsy-derived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models
por: Biery, Matt C., et al.
Publicado: (2020)

Multiple subtentorial metastasis in diffuse midline glioma receiving tumor treating fields: a case report and literature review
por: Liang, Chaofeng, et al.
Publicado: (2021)

Long-term survival of a patient with diffuse midline glioma in the pineal region: A case report and literature review
por: Ono, Takahiro, et al.
Publicado: (2021)

MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT
por: Takezaki, Tatsuya, et al.
Publicado: (2019)

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
por: Zhao, Ji-ping, et al.
Publicado: (2022)

Decoding Diffuse Midline Gliomas: A Comprehensive Review of Pathogenesis, Diagnosis and Treatment
por: Al Sharie, Sarah, et al.
Publicado: (2023)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Ventricular Cerebrospinal Fluid Sampling in Pediatric Diffuse Midline Glioma Patients: Institutional Experience and Review of the Literature
por: Li, Daphne, et al.
Publicado: (2020)

Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma
por: Price, Gabrielle, et al.
Publicado: (2021)

Flank Pain as a First Symptom of a Diffuse Midline Glioma
por: Bassa, Burc, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n9r9d0efg5igodfuhil4rgc15p